Design of a phase II trial comparing tepotinib + gefitinib...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

Design of a phase II trial comparing tepotinib + gefitinib with cisplatin + pemetrexed in EGFR inhibitor-resistant, c-Met+ NSCLC

Wu, Y-L., Park, K., Kim, D-W., Soo, R., Stammberger, U., Chen, W., Locatelli, G., Yang, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw383.87
Date:
October, 2016
File:
PDF, 36 KB
english, 2016
Conversion to is in progress
Conversion to is failed